Annals of Dermatology
ISSN: 1013-9087 | eISSN: 2005-3894
Annals of Dermatology (Ann Dermatol) is the official peer-reviewed publication of the Korean Dermatological Association and the Korean Society for Inv...
View Journal DetailsDiscover 2 from Korean Dermatological Association journals for 2025. Explore both paid and free options with detailed metrics, quartiles, impact factors, submission guidelines, and access types to elevate your research and publishing success.
Discover the best academic journals tailored to your research needs. Our comprehensive directory features thousands of peer-reviewed publications across various disciplines, complete with impact factors, indexing details, and open access options. Whether you're seeking high-impact Q1 journals in social sciences or free-to-publish options in engineering, our advanced filters help you find exactly what you're looking for.
Stay updated with the latest 2025 metrics from Scopus, Web of Science, and more. Explore journals from around the world, filter by country, access type, and publication fees to streamline your literature search.
Use these filters to narrow down journals by subject, impact, access, and more for precise results.
Below are the top 2 journals matching your criteria. Click on a journal to view full details, including submission guidelines and recent articles.
ISSN: 1013-9087 | eISSN: 2005-3894
Annals of Dermatology (Ann Dermatol) is the official peer-reviewed publication of the Korean Dermatological Association and the Korean Society for Inv...
View Journal DetailsISSN: 0494-4739
대한피부과학회지는 피부과 ì˜ì‚¬ë“¤ì´ 만드는, 피부과 ì˜ì‚¬ë“¤ë§Œì„ 위한 êµì˜ë¬¸ ì „ë¬¸í•™ìˆ ì§€ì´ë‹¤. 대한피부과학회...
View Journal DetailsOur directory is updated regularly with the latest metrics to help you make informed decisions.
Impact factors above 3.0 are considered strong, while Q1 quartiles represent the top 25% in their field.
Use our 'No APC' filter under Publication Fees to discover diamond open access options.
Quartiles (Q1-Q4) rank journals by prestige; Q1 is elite for career advancement.